Tvardi Therapeutics, Inc. (TVRD) › Shareholders' EquityTvardi Therapeutics, Inc. (TVRD) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: -$52.06M2012: -$58.13M2013: -$54.08M2014: $51.66M2015: $105.04M2016: $50.73M2017: $86.78M2018: $133.63M2019: $186.71M2020: $249.00M2021: $227.52M2022: $158.78M2023: -$62.06M2024: -$91.13M2025: $20.95M$20.95M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$20.95M+123.0%2024-$91.13M-46.8%2023-$62.06M-139.1%2022$158.78M-30.2%2021$227.52M-8.6%2020$249.00M+33.4%2019$186.71M+39.7%2018$133.63M+54.0%2017$86.78M+71.1%2016$50.73M-51.7%2015$105.04M+103.3%2014$51.66M+195.5%2013-$54.08M+7.0%2012-$58.13M-11.7%2011-$52.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share